PONTREMOLI, SANDRO
 Distribuzione geografica
Continente #
EU - Europa 23.524
AS - Asia 1.869
NA - Nord America 904
SA - Sud America 126
AF - Africa 29
OC - Oceania 17
Totale 26.469
Nazione #
IT - Italia 23.191
SG - Singapore 891
US - Stati Uniti d'America 837
CN - Cina 508
VN - Vietnam 288
FR - Francia 180
BR - Brasile 83
HK - Hong Kong 48
DE - Germania 36
JP - Giappone 28
FI - Finlandia 25
AR - Argentina 24
CA - Canada 24
GB - Regno Unito 21
BD - Bangladesh 19
AU - Australia 17
MX - Messico 17
CH - Svizzera 14
IN - India 14
NL - Olanda 12
ID - Indonesia 11
IQ - Iraq 9
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
ZA - Sudafrica 7
CO - Colombia 6
ES - Italia 6
TR - Turchia 6
IE - Irlanda 5
JO - Giordania 5
KR - Corea 5
PH - Filippine 5
CR - Costa Rica 4
KE - Kenya 4
KZ - Kazakistan 4
RO - Romania 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
DZ - Algeria 3
HN - Honduras 3
MA - Marocco 3
PL - Polonia 3
SE - Svezia 3
TH - Thailandia 3
UA - Ucraina 3
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
MT - Malta 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
TG - Togo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
Totale 26.469
Città #
Genova 15.497
Genoa 4.374
Rapallo 1.858
Vado Ligure 1.383
Singapore 422
San Jose 370
Lauterbourg 172
Ho Chi Minh City 78
New York 74
Ashburn 62
Beijing 60
Hanoi 52
Hong Kong 44
Santa Clara 38
Frankfurt am Main 32
Tokyo 26
Helsinki 25
Council Bluffs 17
Da Nang 16
Bordighera 15
Tianjin 15
Haiphong 14
Zurich 14
Mexico City 11
Montreal 11
Amsterdam 10
Los Angeles 9
São Paulo 7
Toronto 7
Buffalo 6
Dallas 6
Dublin 6
Hải Dương 6
Madrid 6
Orem 6
San Francisco 6
Chicago 5
Des Moines 5
Kingston 5
Rome 5
Amman 4
Baghdad 4
Cardiff 4
City of London 4
Guangzhou 4
Johannesburg 4
London 4
Mumbai 4
Nha Trang 4
Ninh Bình 4
Palermo 4
Paris 4
Phoenix 4
Quảng Ngãi 4
Rio de Janeiro 4
Sydney 4
Wuhan 4
Abu Dhabi 3
Acalanes Ridge 3
Atlanta 3
Biên Hòa 3
Buenos Aires 3
Can Tho 3
Catania 3
Changsha 3
Curtea de Argeş 3
Fortaleza 3
Istanbul 3
Jacksonville 3
Jeddah 3
Marseille 3
Milan 3
Nairobi 3
Naples 3
San José 3
Tây Ninh 3
Vĩnh Long 3
Warsaw 3
Addis Ababa 2
Algiers 2
Almaty 2
Ananindeua 2
Ankara 2
Bari 2
Belgrade 2
Bengaluru 2
Bogotá 2
Brasília 2
Brooklyn 2
Buon Ma Thuot 2
Cagliari 2
Campinas 2
Charlotte 2
Copenhagen 2
Córdoba 2
Dhaka 2
Dubai 2
Florence 2
Greensboro 2
Guarulhos 2
Totale 24.950
Nome #
"Intracellular calpastatin proteolysis: a salvage mechanism or a prelude to cell damage?" 265
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients 243
Calpain digestion and HSP90-based chaperone protection modulate the level of plasma membrane F508del-CFTR. 238
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients 222
A vincristine-resistant murine erythroleukemia cell line secretes a differentiation enhancing factor. 210
Role of the calpain-calpastatin system in the density-dependent growth arrest 209
Acyl-CoA-binding protein is a potent m-calpain activator 203
Autolysis of human erythrocytes calpain produces two active enzyme forms with different cell localization 199
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. 197
Modulation of the calpain autoproteolysis by calpastatin and phospholipids 196
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 191
Characterization of a new p94-like calpain form in human lymphocytes 189
Activation by hemoglobin of the Ca2+-requiring neutral proteinase of human erythrocytes: structural requirements. 189
Effect of extremely low frequency magnetic fields on calpain activation 187
Physiological Roles of Calpain 1 Associated to Multiprotein NMDA Receptor Complex. 187
Activation of neutrophil calpain following its translocation to the plasma membrane induced by phorbol ester or fMet-Leu-Phe.. 184
Differential regulation of the calpain-calpastatin complex by the L-domain of calpastatin 183
Involvement of exon 6-mediated calpastatin intracellular movements in the modulation of calpain activation. 182
Binding to erythrocyte membrane is the physiological mechanism for activation of Ca2+-dependent neutral proteinase. 180
Carbon tetrachloride-induced inhibition of protein kinase C in isolated rat hepatocytes. 178
Pathological role of the calpain/calpastatin system in cystic fibrosis 177
Degradation of CFTR-generated protein clusters by calpain: A physiological or a pathological role? 174
Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli 172
Characterization of the defective calpain-endogenous calpain inhibitor system in erythrocytes from Milan hypertensive rats. 171
Changes in calpastatin localization and expression during calpain activation: a new mechanism for the regulation of intracellular Ca(2+)-dependent proteolysis. 169
A dual role for the Ca2+-requiring proteinase in the degradation of hemoglobin by erythrocyte membrane proteinases. 168
Activation of NADPH oxidase and phosphorylation of membrane proteins in human neutrophils: coordinate inhibition by a surface antigen-directed monoclonal antibody. 168
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. 167
Cathepsin M: a lysosomal proteinase with aldolase-inactivating activity 167
Binding of protein kinase C to neutrophil membranes in the presence of Ca2+ and its activation by a Ca2+-requiring proteinase. 167
Glucose 6-phosphate dehydrogenase activity in membranes of erythrocytes from normal individuals and subjects with Mediterranean G6PD deficiency. 167
Changes during fasting in the activity of a specific lysosomal proteinase, fructose-1,6-bisphosphatase converting enzyme. 167
Changes in rabbit-liver lysosomes and fructose 1,6-bisphosphatase induced by cold and fasting. 167
Characterization of the inactive form of fructose-1,6-bisphosphate aldolase isolated from livers of fasted rabbits. 165
Regulation of calpain activity in rat brain with altered Ca2+ homeostasis 164
Properties and intracellular localization of calpain activator protein 164
Binding of Zn2+ to rabbit muscle fructose 1,6-bisphosphatase and its effect on the catalytic properties. 163
Interactions of Zn2+ and Mg2+ with rabbit liver fructose 1,6 bisphosphatase. 162
Multiple rat brain calpastatin forms are produced by distinct starting points and alternative splicing of the N-terminal exons. 162
Protein kinase C isoforms in murine erythroleukemia cells and their involvement in the differentiation process. 162
The role of calpain in the selective increased phosphorylation of the anion-transport protein in red cell of hypertensive subjects. 161
On the mechanism of inhibition of fructose 1,6-bisphosphatase by fructose 2,6-bisphosphate. 161
The calpain-calpastatin system in cystic fibrosis: physiopathological implications 161
"Association of calpastatin with inactive calpain: a novel mechanism to control the activation of the protease?" 161
Changes in intracellular localization of calpastatin during calpain activation 160
Potentiation of NMDA Receptor-Dependent Cell Responses by Extracellular High Mobility Group Box 1 Protein. 160
Changes in intracellular calpastatin localization are mediated by reversible phosphorylation 158
Interaction between Calpain-1 and HSP90: New Insights into the Regulation of Localization and Activity of the Protease. 158
Extralysosomal protein degradation. 156
Proteolytic degradation of nitric oxide synthase isoforms by calpain is modulated by the expression levels of HSP90. 156
Age-dependent degradation of calpastatin in kidney of hypertensive rats 156
“In vivo degradation of Nitric-Oxide Synthase isozymes by Calpain is regulated by HSP90” 155
Cytosolic calcium dependent proteinase of human erythrocytes: formation of an enzyme-natural inhibitor complex induced by Ca2+ ions. 154
Identification of a novel neutrophil membrane protein involved in modulation of oxidative burst. 153
Antisense oligodeoxynucleotide inhibition of delta protein kinase C expression accelerates induced differentiation of murine erythroleukaemia cells 153
Binding of monoclonal antibody to cathepsin M located on the external surface of rabbit lysosomes. 153
Inactivation of liver aldolase in fasting rabbits: evidence for the accumulation of two different immunoreactive forms. 152
Comparative patterns of 'in vitro' oxidative hemolysis of normal and glucose 6-phosphate dehydrogenase (G6PD)-deficient erythrocytes. 152
Biochemical responses in activated human neutrophils mediated by protein kinase C and a Ca2+-requiring proteinase. 151
Changes in activity of fructose-1,6-bisphosphate aldolase in livers of fasted rabbits and accumulation of crossreacting immune material. 151
Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation 150
Decreased level of calpain inhibitor activity in kidney from Milan hypertensive rats. 150
Role of calpain in the regulation of CFTR (cystic fibrosis transmembrane conductance regulator) turnover 150
The plasma membrane calcium pump is the preferred calpain substrate within the erythrocyte 148
Phosphorylation and proteolytic modification of specific cytoskeletal proteins in human neutrophils stimulated by phorbol 12-myristate 13-acetate. 148
Fructose-1, 6-diphosphatase from rabbit liver. 148
Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation. 148
Isolation and characterization of calpain activator protein from bovine brain. 147
Fructose 1,6-bisphosphatase: the role of lysosomal enzymes in the modification of catalytic and structural properties. 147
ATP induces the release of a neutral serine proteinase and enhances the production of superoxide anion in membranes from phorbol ester-activated neutrophils. 147
Inactivation of fructose 1,6-bisphosphatase by a lysosomal proteinase is reversed by cystamine. 146
Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms. 146
Cytosolic levels of calpastatin are regulated by limited proteolysis 146
The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. 146
Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis 146
Fructose 1,6-bisphosphatase: properties of the neutral enzyme and its modification by proteolytic enzymes. 145
Two cytosolic, Ca2+-dependent, neutral proteinases from rabbit liver: purification and properties of the proenzymes. 145
Endogenous inhibitors of lysosomal proteinases 144
Stimulation of erythroleukaemia cell differentiation by extracellular high mobility group-box protein 1 is independent of receptor for advanced glycation end products. 143
“Susceptibility of NOS isoforms to calpain digestion is modulated by the expression levels of HSP90” 143
A Novel signalling mechanism promoting Ca(2+) driven cell responses through high-mobility group box-1/NMDA receptor interaction. 143
The carboxy-terminal amino acid sequence of rabbit liver fructose 1,6-bisphosphatase. 142
Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation 142
Modulation of the intracellular Ca2+-dependent proteolytic system is critically correlated with the kinetics of differentiation of murine erythroleukemia cells 141
Vincristine-resistant erythrolekaemia cell line has marked increase sensitivity to examethylenebisacetamide-induced differentiation 141
Role of calpain-1 in the early phase of experimental ALS 141
Functional role of the charge at the T538 residue in the control of protein kinase Ctheta 140
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein 140
In vitro correction of erythrocyte glucose 6-phosphate dehydrogenase (G6PD) deficiency. 140
Characterization of the biological role of murine erythroleukemia cells "differentiation enhancing factor" using antisense oligodeoxynucleotides. Biochem. Biophys. Res. Commun. 193, 941-947 139
Calpain-mediated activation of NO synthase in human neuroblastoma SK-N-BE cells 139
Rabbit liver fructose 1,6-diphosphatase. Properties of the native enzyme and their modification by subtilisin. 139
The liver aldolase-fructose bisphosphatase complex. 139
Differentiation of murine erythroleukemia cells by hexamethylenebisacetamide involves secretion and binding to membranes of a differentiation enhancing factor. 139
Selective proinflammatory activation of astrocytes by high mobility group box 1 protein signaling 138
Introduction of beta isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells 137
Different susceptibility of red cell membrane proteins to calpain degradation. 137
Origin of tryptophan in fructose 1,6-bisphosphatase purified from livers of fed rabbits. 137
An endogenous activator of the Ca2+-dependent proteinase of human neutrophils that increases its affinity for Ca2+. 137
Differentiation of HL60 promyelocytic cells is promoted by a "differentiation enhancing factor" produced by erythroleukemia cells" 136
Totale 16.217
Categoria #
all - tutte 74.675
article - articoli 68.606
book - libri 0
conference - conferenze 5.409
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 660
Totale 149.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 0 0 0 0 0 115 125
2021/20222.208 48 144 144 247 99 156 173 453 101 232 94 317
2022/20232.216 203 111 17 288 349 449 1 150 416 10 191 31
2023/2024986 54 131 9 102 139 237 33 34 58 18 50 121
2024/20253.284 176 246 90 204 501 362 246 448 134 124 313 440
2025/20264.487 610 98 216 316 599 543 883 199 435 442 146 0
Totale 26.580